In most cell types, NF-kappa B is activated by release from a cytoplas
mic inhibitor protein, I kappa B, followed by its translocation to the
nucleus where it binds to the regulatory regions of many genes, inclu
ding the IL-2 gene in T lymphocytes. We have previously shown by elect
rophoretic mobility shift assays that nuclear extracts prepared from a
ctivated, non-IL-2-producing Th2 cell clones contain significantly les
s p65(RelA)-p50 NF-kappa B complexes than nuclear extracts from IL-2-p
roducing Th1 and Th0 clones. We show here that Th1 and Th2 cells have
similar levels of cytoplasmic p65(RelA) and p50, but TCR stimulation f
ails to induce the nuclear translocation of p65(RelA) in Th2 cells. Nu
clear translocation of p65(RelA) can be induced by IL-1 stimulation of
Th2 cells, indicating that a basic mechanism of NF-kappa B activation
common to many cells is intact in Th2 cells. We demonstrate that IL-1
and TNF induce rapid nuclear translocation of p65(RelA) in T cell clo
nes, whereas TCR-induced NF-kappa B activation in Th1 cells is delayed
and may be longer in duration. This suggests that the TCR pathway of
NF-kappa B activation is different from the cytokine pathway. Furtherm
ore, we show that Th1 and Th2 cells express different levels and/or di
fferent forms of I kappa B alpha, and that cytokines, but not TCR stim
uli, significantly modulate detectable levels of cytoplasmic I kappa B
alpha.